JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, L. G.
Right arrow Articles by Garg, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, L. G.
Right arrow Articles by Garg, M. L.
Journal of the American College of Nutrition, Vol. 22, No. 4, 253-257 (2003)
Published by the American College of Nutrition


Review

Hypothesis: Vitamin E Complements Polyunsaturated Fatty Acids in Essential Fatty Acid Deficiency in Cystic Fibrosis

Lisa G. Wood, PhD, Dominic A. Fitzgerald, MBBS, PhD and Manohar L. Garg, PhD

Discipline of Nutrition and Dietetics, University of Newcastle, Callaghan (L.G.W., M.L.G.), New South Wales, AUSTRALIA
Department of Respiratory Medicine, The Children’s Hospital at Westmead, Sydney (D.A.F.),New South Wales, AUSTRALIA

Address reprint requests to: Manohar L. Garg, PhD, Discipline of Nutrition & Dietetics, University of Newcastle, Callaghan, NSW, 2308, AUSTRALIA. E-mail: ndmg{at}mail.newcastle.edu.au

While several studies have demonstrated essential fatty acid (EFA) deficiency in plasma and tissue lipids of cystic fibrosis (CF) patients, the reasons for this deficiency are not well established. It is believed that reduced EFA intake, malabsorption of fat, altered desaturase/lipase activity and defective cystic fibrosis transmembrane conductance regulator (CFTR) altering utilisation of EFA in epithelial cells contribute to the development of EFA deficiency in CF. It is likely that increased metabolism of arachidonic acid to eicosanoids such as leukotrienes, thromboxane and prostaglandins may also be a contributing factor. Evidence is presented that elevated oxidative damage to EFA and impaired antioxidant defences, in particular vitamin E, may contribute to the development of EFA deficiency in CF. Furthermore, antioxidant supplementation in CF may improve EFA status.

Key words: cystic fibrosis, vitamin E, essential fatty acids, antioxidants, oxidative stress




This article has been cited by other articles:


Home page
Therapeutic Advances in Respiratory DiseaseHome page
A. Sharafkhaneh, S. Velamuri, V. Badmaev, C. Lan, and N. Hanania
Review: The potential role of natural agents in treatment of airway inflammation
Therapeutic Advances in Respiratory Disease, December 1, 2007; 1(2): 105 - 120.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Nutrition.